語言

Congratulations to Hsin-Hung Lin for being selected to attend the Fifth HOPE meeting

2012terry-PIsLeft to right:Dr. John Yu, Doctoral student Hsin-Hung Lin and Dr. Alice Yu Doctoral student Hsin-Hung Lin of Dr. Alice Yu’s lab has been invited, along with other 5 participants from Academia Sinica, to attend the 2013 HOPE meeting.

In Lin’s study co-led by Dr. Alice Yu and Dr. John Yu, a novel protein, designated as YULINK, has been proved to be involved in the venous specification. A demonstration has been made showing how YULINK regulates venous vascular tube formation through VEGFR2-mediated endocytosis in zebra fish as well as human endothelial cells. Lin will present this study in the coming event.

HOPE Meetings with Nobel Laureates is an annual event sponsored by Japan Society for the Promotion of Science (JSPS) since 2007. This event is designed to give opportunities to excellent graduate students and young researchers selected from countries and areas in the Asia-Pacific region to engage in interdisciplinary discussions with Nobel laureates and other distinguished scientists pioneering the frontiers of knowledge.

Invited participants for the 2013 event are from countries including Australia, Bangladesh, China, Egypt, India, Indonesia, Israel, Japan, Korea, Malaysia, Mongolia, New Zealand, Philippines, Singapore, South Africa, Taiwan, Thailand, and Vietnam.

For more information, please see: http://www.jsps.go.jp/english/e-hope/outline.html

 

LATEST NEWS

  • The Next Chapter of Precision Chemical Modification: From Natural Product Inspirations to Efficient Drugs for Rare Disease +

    Read More
  • Sulfated Disaccharides Repair Toxic Protein Gain-of-Function, a New Approach to Treatment of Amyotrophic Lateral Sclerosis +

    Read More
  • Unveiling the Mystery of Cancer-Causing KRAS Gene Driving Pancreatic Precancerous Lesions +

    Read More
  • Unveiling Antigen Presentation and Cross-reactive Antibody Response of an Oligosaccharide-conjugate Vaccine, Paving the Way for Advanced Cancer Vaccines +

    Read More
  • Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc +

    Read More
  • 1
  • 2